ATE290385T1 - Arzneimittel zur förderung der neuronalen zelldifferenzierung, die cyclische glycerophosphate und deren analoga enthalten - Google Patents
Arzneimittel zur förderung der neuronalen zelldifferenzierung, die cyclische glycerophosphate und deren analoga enthaltenInfo
- Publication number
- ATE290385T1 ATE290385T1 AT00912877T AT00912877T ATE290385T1 AT E290385 T1 ATE290385 T1 AT E290385T1 AT 00912877 T AT00912877 T AT 00912877T AT 00912877 T AT00912877 T AT 00912877T AT E290385 T1 ATE290385 T1 AT E290385T1
- Authority
- AT
- Austria
- Prior art keywords
- cgs
- nerve
- analogs
- resulting
- activities
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
- A61K31/6615—Compounds having two or more esterified phosphorus acid groups, e.g. inositol triphosphate, phytic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Psychiatry (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Obesity (AREA)
- Psychology (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Emergency Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL12917899A IL129178A0 (en) | 1999-03-25 | 1999-03-25 | Induction of nerve generation |
PCT/IL2000/000185 WO2000057865A2 (en) | 1999-03-25 | 2000-03-24 | Pharmaceutical compositions comprising cyclic glycerophosphates and analogs thereof for promoting neural cell differentiation |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE290385T1 true ATE290385T1 (de) | 2005-03-15 |
Family
ID=11072645
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT00912877T ATE290385T1 (de) | 1999-03-25 | 2000-03-24 | Arzneimittel zur förderung der neuronalen zelldifferenzierung, die cyclische glycerophosphate und deren analoga enthalten |
Country Status (16)
Country | Link |
---|---|
US (1) | US6914056B1 (de) |
EP (1) | EP1162959B1 (de) |
JP (1) | JP2002540146A (de) |
KR (1) | KR20010112364A (de) |
CN (1) | CN1348375A (de) |
AT (1) | ATE290385T1 (de) |
AU (1) | AU768911B2 (de) |
BR (1) | BR0009296A (de) |
CA (1) | CA2368597A1 (de) |
DE (1) | DE60018554T2 (de) |
HK (1) | HK1042038A1 (de) |
IL (1) | IL129178A0 (de) |
MX (1) | MXPA01009650A (de) |
NZ (1) | NZ514525A (de) |
RU (1) | RU2247557C2 (de) |
WO (1) | WO2000057865A2 (de) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69912808T2 (de) | 1999-12-08 | 2004-09-30 | Centre National De La Recherche Scientifique (C.N.R.S.) | Verwendung von Hymenialdisin und dessen Derivaten zur Herstellung therapeutischer Mittel |
JP4815063B2 (ja) * | 2001-04-13 | 2011-11-16 | きみ子 室伏 | 環状ホスファチジン酸を含むグリア細胞の増殖、分化及び/又は生存の促進のための薬剤 |
JP4836345B2 (ja) * | 2001-04-13 | 2011-12-14 | きみ子 室伏 | 環状ホスファチジン酸誘導体を含む神経細胞の生存促進剤 |
IL148665A0 (en) * | 2002-03-13 | 2002-09-12 | Yeda Res & Dev | Derivatives of 1,3-cyclic propandiol phate and their action as cell stimulants |
IL148668A0 (en) * | 2002-03-13 | 2002-09-12 | Yeda Res & Dev | Derivatives of 1,3-cyclic propandiol phosphate and their action in differentiation therapy |
AU2003220521A1 (en) * | 2002-03-27 | 2003-10-13 | Smithkline Beecham Corporation | Methods of treatment with lxr modulators |
JP4162927B2 (ja) | 2002-06-11 | 2008-10-08 | きみ子 室伏 | カルバ環状ホスファチジン酸誘導体 |
WO2006097924A2 (en) * | 2005-03-14 | 2006-09-21 | Yeda Research And Development Company Ltd. | Cyclic phosphates as plant growth regulators |
PL2011796T3 (pl) * | 2006-04-26 | 2015-03-31 | Toyama Chemical Co Ltd | Induktor neurogenezy lub środek terapeutyczny do stosowania w neuropatii zawierający pochodną eteru alkilowego lub jej sól |
KR20090097943A (ko) * | 2006-12-28 | 2009-09-16 | 오짜노미즈 유니버시티 | 환상 포스파티딘산 유도체를 포함하는 진통제 |
CN102272080A (zh) * | 2009-01-09 | 2011-12-07 | 西格马-奥利奇有限公司 | β磷酸甘油的合成方法 |
WO2011065480A1 (ja) * | 2009-11-26 | 2011-06-03 | 国立大学法人お茶の水女子大学 | 神経細胞死抑制剤 |
EP2949329B1 (de) * | 2013-01-28 | 2019-05-01 | Ochanomizu University | Therapeutikum gegen demyelinisierende krankheit |
EP2807925A1 (de) * | 2013-05-26 | 2014-12-03 | Symrise AG | Antimikrobielle Zusammensetzungen |
CN108473519A (zh) * | 2015-12-08 | 2018-08-31 | 雷特罗芬公司 | 用于治疗神经疾病的环状磷酸酯和环状氨基磷酸酯 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL63037A (en) * | 1981-06-04 | 1985-12-31 | Israel State | Dioxaphosphorinanes,their preparation and pharmaceutical and veterinary compositions containing them |
US5565439A (en) | 1992-11-24 | 1996-10-15 | The Procter & Gamble Company | Methods of using lysophosphatidic acid for treating hyperproliferative conditions |
JPH06228169A (ja) * | 1993-02-05 | 1994-08-16 | Sagami Chem Res Center | 1−o−アシルグリセロール2,3−ホスフェートの製造法 |
JPH07149772A (ja) * | 1993-11-26 | 1995-06-13 | Sagami Chem Res Center | タンパク質リン酸化酵素cの活性促進剤 |
JPH07258278A (ja) * | 1994-03-18 | 1995-10-09 | Sagami Chem Res Center | 1−O−アシルグリセロール−2,3−ホスフェート誘導体を有効成分とするDNAポリメラーゼαの阻害剤 |
JPH0925235A (ja) * | 1995-07-13 | 1997-01-28 | Sagami Chem Res Center | 1−o−アシルグリセロール−2,3−ホスフェート誘導体を有効成分とするがん転移抑制剤 |
US6150345A (en) * | 1998-08-10 | 2000-11-21 | Regents Of The University Of California | Methods for promoting survival of myelin producing cells |
IL129179A0 (en) | 1999-03-25 | 2000-02-17 | Yeda Res & Dev | Cyclic glycerophosphates and analogs thereof |
-
1999
- 1999-03-25 IL IL12917899A patent/IL129178A0/xx unknown
-
2000
- 2000-03-24 EP EP00912877A patent/EP1162959B1/de not_active Expired - Lifetime
- 2000-03-24 WO PCT/IL2000/000185 patent/WO2000057865A2/en not_active Application Discontinuation
- 2000-03-24 JP JP2000607616A patent/JP2002540146A/ja active Pending
- 2000-03-24 NZ NZ514525A patent/NZ514525A/en unknown
- 2000-03-24 CN CN00806738A patent/CN1348375A/zh active Pending
- 2000-03-24 BR BR0009296-7A patent/BR0009296A/pt not_active IP Right Cessation
- 2000-03-24 RU RU2001128743/15A patent/RU2247557C2/ru not_active IP Right Cessation
- 2000-03-24 DE DE60018554T patent/DE60018554T2/de not_active Expired - Fee Related
- 2000-03-24 MX MXPA01009650A patent/MXPA01009650A/es not_active Application Discontinuation
- 2000-03-24 AU AU34517/00A patent/AU768911B2/en not_active Ceased
- 2000-03-24 KR KR1020017012158A patent/KR20010112364A/ko not_active Application Discontinuation
- 2000-03-24 CA CA002368597A patent/CA2368597A1/en not_active Abandoned
- 2000-03-24 AT AT00912877T patent/ATE290385T1/de not_active IP Right Cessation
- 2000-03-24 US US09/936,922 patent/US6914056B1/en not_active Expired - Fee Related
-
2002
- 2002-03-04 HK HK02101620.4A patent/HK1042038A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
WO2000057865A2 (en) | 2000-10-05 |
CA2368597A1 (en) | 2000-10-05 |
EP1162959A2 (de) | 2001-12-19 |
EP1162959B1 (de) | 2005-03-09 |
KR20010112364A (ko) | 2001-12-20 |
IL129178A0 (en) | 2000-02-17 |
CN1348375A (zh) | 2002-05-08 |
BR0009296A (pt) | 2001-12-18 |
DE60018554D1 (de) | 2005-04-14 |
HK1042038A1 (zh) | 2002-08-02 |
WO2000057865A3 (en) | 2001-06-28 |
JP2002540146A (ja) | 2002-11-26 |
MXPA01009650A (es) | 2002-07-02 |
WO2000057865A9 (en) | 2001-11-15 |
AU3451700A (en) | 2000-10-16 |
DE60018554T2 (de) | 2006-04-13 |
AU768911B2 (en) | 2004-01-08 |
RU2247557C2 (ru) | 2005-03-10 |
NZ514525A (en) | 2003-10-31 |
US6914056B1 (en) | 2005-07-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE290385T1 (de) | Arzneimittel zur förderung der neuronalen zelldifferenzierung, die cyclische glycerophosphate und deren analoga enthalten | |
EP0348353A3 (en) | The use of physiologically active substances for the manufacture of drugs for cerebral and neuronal diseases | |
ZA902153B (en) | Use of 5-methyltetrahydrofolic acid,5-formyltetrahydrofolic acid and their pharmaceutically acceptable salts in the preparation of pharmaceutical compositions in controlled-release form active in the therapy of organic mental disturbances and the relative pharmaceutical compositions | |
ATE290867T1 (de) | Synthetische katalytische freie radikalfänger, verwendbar als antioxidantien zur prävention und therapie von krankheiten | |
EP0616032A3 (de) | Verbeugende oder therapeutische Mittel für die Alzheimer-Krankheit, eine Siebtest-Methode, und die menschliche Tau-Protein-Kinase. | |
ATE271874T1 (de) | Verwendung von inosine zur herstellung eines medikamentes zur stimulierung des axonwachstums von zns-neuronen | |
IL104006A (en) | Azaheterocyclylmethyl-chromans their preparation and pharmaceutical compositions containing them | |
PL342078A1 (en) | Inhibition of raf kinase using symmetrical and dissymmetrical substituted dimethylureas | |
EP0858996A4 (de) | Mittel zum schutz von nervenzellen | |
ATE444077T1 (de) | Präventiva und therapeutika für mit demyelinisierung-assozierten erkrankungen | |
ATE213411T1 (de) | Verwendung von phenserin zur herstellung von medikamenten zur behandlung von kognitiven störungen | |
CA2122058A1 (en) | Tgf-beta to improve neural outcome | |
EP0103290A3 (de) | Pharmazeutische Zubereitungen zur Behandlung von unerwünschten Verwachsungen sowie deren Verwendung | |
DE69636934D1 (de) | Verwendung von aromatischen oder verzweigten aminosäuren zur behandlung von bewegungsstörungen | |
ATE167060T1 (de) | Epidermis-wachstumsfaktor als arzneimittel zur wiederherstellung der neuronen der substantia nigra in der behandlung nervenzerstörender störungen | |
Gustafson et al. | Effects of piracetam on regional cerebral blood flow and mental functions in patients with organic dementia | |
PL310950A1 (en) | Novel imidazole quinoxalinones, method of obtaining them and their application | |
DE60039579D1 (de) | Humane adulte astrozyten, sowie deren herstellung und verwendung | |
ATE143809T1 (de) | Placentaextrakt und verfahren zu seiner herstellung | |
DE60109651T2 (de) | Carnitin und huperzin enthaltende zusammensetzungen zur behandlung und vorbeugung von hyperaktivität mit aufmerksamkeitstörungen bei kindern | |
DE68901172D1 (de) | (-)-2-pyrazolinverbindung, deren optischen aufspaltung und therapeutisches agens zur behandlung von zerebralen gefaesskrankheiten, diese verbindung als aktives ingredient enthaltend. | |
JPS5753475A (en) | Novel thiazolyl-2-oxamic acid derivative, manufacture and medicine containing same | |
WO2002076437A3 (en) | Methods for treating neurodegenerative diseases including alzheimer's | |
DE3369640D1 (en) | Pharmaceutical composition useful for improvement and/or treatment of mental symptoms caused by organic disorder in brain | |
WO2000001440A3 (en) | Methods for treating neurological injuries and disorders |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |